Liposomal drug delivery systems: From concept to clinical applications

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954 · see citing works

Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · see citing works

Diffusion of univalent ions across the lamellae of swollen phospholipids

Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · see citing works

Drug Delivery Systems: Entering the Mainstream

Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works

Delivering nanomedicine to solid tumors

Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,196 · see citing works

Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

Szoka, F. C., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,333 · see citing works

Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential

Hope, M. J., Bally, M. B., Webb, G., & Cullis, P. R. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90521-8 · Cited by 2,082 · see citing works

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · see citing works

Vesicles of variable sizes produced by a rapid extrusion procedure

Mayer, L. D., Hope, M. J., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90302-0 · Cited by 1,693 · see citing works

Ligand-targeted therapeutics in anticancer therapy

Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648 · see citing works

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Papahadjopoulos, D., Allen, T. M., Gabizón, A., Mayhew, E. G., Matthay, K. K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasiç, D. D., & Redemann, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,621 · see citing works

Phosphatidylcholine vesicles. Formation and physical characteristics

Huang, C.-H. (1969) · Biochemistry · doi:10.1021/bi00829a048 · Cited by 1,534 · see citing works

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

Allen, T. M., Hansen, C., Martin, F., Redemann, C. T., & Yau‐Young, A. O. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,392 · see citing works

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.

Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382 · see citing works

Single bilayer liposomes prepared without sonication

Batzri, S., & Korn, E. D. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90408-2 · Cited by 1,362 · see citing works

RNAi-mediated gene silencing in non-human primates

Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · see citing works

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324 · see citing works

Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.

Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y.-L., Border, R., Ramsey, P., Martin, M. U., & Felgner, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41980-6 · Cited by 1,313 · see citing works

Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276 · see citing works

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267 · see citing works

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261 · see citing works

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129 · see citing works

Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes

Olson, F. C., Hunt, C. A., Szoka, F. C., Vail, W. J., & Papahadjopoulos, D. (1979) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(79)90085-3 · Cited by 1,126 · see citing works

Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers

Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 911 · see citing works

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777 · see citing works

A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.

Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746 · see citing works

Large unilamellar liposomes with low uptake into the reticuloendothelial system

Allen, T. M., & Chonn, A. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80506-9 · Cited by 729 · see citing works

Liposomes for the sustained drug release in vivo

Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 701 · see citing works

Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.

Lee, R., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 694 · see citing works

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA

Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685 · see citing works

Liposomes as immunological adjuvants

Allison, A. C., & Gregoriadis, G. C. (1974) · Nature · doi:10.1038/252252a0 · Cited by 676 · see citing works

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J. C., Guthrie, T. H., Shah, P. M., Khojasteh, A., Nair, M. K., Hoelzer, K. L., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669 · see citing works

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2

Bressler, N. M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01237-5 · Cited by 666 · see citing works

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · PubMed · Cited by 647 · see citing works

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A. C., Bow, E. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 623 · see citing works

Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

Safra, T., Muggia, F. M., Jeffers, S., Tsao-Wei, D. D., Groshen, S. G., Lyass, O., Henderson, R., Berry, G. J., & Gabizón, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618 · see citing works

The Carrier Potential of Liposomes in Biology and Medicine

Gregoriadis, G. C. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609232951305 · Cited by 595 · see citing works

GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery

Li, W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.041 · Cited by 588 · see citing works

Pharmacokinetics of stealth versus conventional liposomes: effect of dose

Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579 · see citing works

Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575 · see citing works

Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo

Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571 · see citing works

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

Leamon, C. P., & Low, P. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5572 · Cited by 558 · see citing works

RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING

Torchilin, V. P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095735 · Cited by 542 · see citing works

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

Glantz, M., Jaeckle, K. A., Chamberlain, M. C., Phuphanich, S., Recht, L. D., Swinnen, L. J., Maria, B., LaFollette, S., Schumann, G. B., Cole, B. F., et al. (1999) · PubMed · Cited by 529 · see citing works

The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs

Juliano, R. L., & Stamp, D. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(75)80433-5 · Cited by 523 · see citing works

Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles

Senior, J. H., Delgado, C., Fisher, D., Tilcock, C., & Gregoriadis, G. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90337-8 · Cited by 521 · see citing works

On the formulation of pH-sensitive liposomes with long circulation times

Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 485 · see citing works

Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target

Klibanov, A. L., Maruyama, K., Beckerleg, A. M., Torchilin, V. P., & Huang, L. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90385-l · Cited by 480 · see citing works

Serum-induced leakage of liposome contents

Allen, T. M., & Cleland, L. G. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90118-2 · Cited by 472 · see citing works

Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes.

Chonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 461 · see citing works

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454 · see citing works

Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors

Laginha, K. M., Verwoert, S., Charrois, G. J. R., & Allen, T. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0343 · Cited by 441 · see citing works

Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells

Filion, M. C., & Phillips, N. C. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00126-0 · Cited by 428 · see citing works

Targeted Liposomal Drug Delivery to Monocytes and Macrophages

Kelly, C., Jefferies, C. A., & Cryan, S. (2010) · Journal of Drug Delivery · doi:10.1155/2011/727241 · Cited by 426 · see citing works

Introduction of liposome-encapsulated SV40 DNA into cells.

Fraley, R. T., Subramani, S. E., Berg, P. R., & Papahadjopoulos, D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70482-7 · Cited by 416 · see citing works

p H-Sensitive Liposomes: Possible Clinical Implications

Yatvin, M. B., Kreutz, W., Horwitz, B. A., & Shinitzky, M. (1980) · Science · doi:10.1126/science.7434025 · Cited by 415 · see citing works

Drug entrapment in liposomes

Gregoriadis, G. C. (1973) · FEBS Letters · doi:10.1016/0014-5793(73)80394-1 · Cited by 414 · see citing works

Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.

Juweid, M. E., Neumann, R. D., Paik, C. H., Pérez-Bacete, M., Sato, J., van Osdol, W. W., & Weinstein, J. N. (1992) · PubMed · Cited by 406 · see citing works

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

Lopez‐Berestein, G., Fainstein, V., Hopfer, R. L., Mehta, K. M., Sullivan, M. P., Keating, M., Rosenblum, M. G., Mehta, R. S., Luna, M. A., Hersh, E. M., et al. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.4.704 · Cited by 405 · see citing works

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

Glantz, M., LaFollette, S., Jaeckle, K. A., Shapiro, W., Swinnen, L. J., Rozental, J. R., Phuphanich, S., Rogers, L. R., Gutheil, J. C., Batchelor, T. T., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3110 · Cited by 402 · see citing works

The effect of cholesterol on the structure of phosphatidylcholine bilayers

McIntosh, T. J. (1978) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(78)90110-4 · Cited by 394 · see citing works

Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles

Straubinger, R. M., Hong, K., Friend, D. S., & Papahadjopoulos, D. (1983) · Cell · doi:10.1016/0092-8674(83)90291-x · Cited by 393 · see citing works

Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A

Leserman, L., Barbet, J., Kourilsky, F. M., & Weinstein, J. N. (1980) · Nature · doi:10.1038/288602a0 · Cited by 391 · see citing works

Challenges in Development of Targeted Liposomal Therapeutics

Sawant, R. R., & Torchilin, V. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9330-0 · Cited by 382 · see citing works

Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy

Drummond, D. C., Noble, C. O., Guo, Z., Hong, K., Park, J. W., & Kirpotin, D. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4007 · Cited by 381 · see citing works

Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient

Mayer, L. D., Bally, M. B., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90105-7 · Cited by 378 · see citing works

Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo

Mori, A., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80699-4 · Cited by 369 · see citing works

Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer

Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 368 · see citing works

Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated Tumors

Weinstein, J. N., Magin, R. L., Yatvin, M. B., & Zaharko, D. S. (1979) · Science · doi:10.1126/science.432641 · Cited by 363 · see citing works

Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals

Papahadjopoulos, D., & Watkins, J. C. (1967) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(67)90095-8 · Cited by 358 · see citing works

Nucleic Acid Delivery: The Missing Pieces of the Puzzle?

Nguyen, J., & Szoka, F. C. (2012) · Accounts of Chemical Research · doi:10.1021/ar3000162 · Cited by 347 · see citing works

Bottom-Up Design and Synthesis of Limit Size Lipid Nanoparticle Systems with Aqueous and Triglyceride Cores Using Millisecond Microfluidic Mixing

Zhigaltsev, I. V., Belliveau, N. M., Hafez, I. M., Leung, A. K. K., Huft, J., Hansen, C. L., & Cullis, P. R. (2012) · Langmuir · doi:10.1021/la204833h · Cited by 346 · see citing works

Tumor targeting using anti-her2 immunoliposomes

Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335 · see citing works

A Double‐Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients

Bowden, R. A., Chandrasekar, P. H., White, M. H., Li, X., Pietrelli, L. A., Gurwith, M., van Burik, J., Laverdière, M., Safrin, S., & Wingard, J. R. (2002) · Clinical Infectious Diseases · doi:10.1086/341401 · Cited by 334 · see citing works

A Nanoparticle Size Series for In Vivo Fluorescence Imaging

Popović, Z., Liu, W., Chauhan, V. P., Lee, J., Wong, C., Greytak, A. B., Insin, N., Nocera, D. G., Fukumura, D., Jain, R. K., et al. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003142 · Cited by 332 · see citing works

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Bally, M. B., & Janoff, A. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0118 · Cited by 332 · see citing works

Accelerated clearance of PEGylated liposomes in rats after repeated injections

Ishida, T., Maeda, R., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00462-5 · Cited by 327 · see citing works

Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens

Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322 · see citing works

The Carrier Potential of Liposomes in Biology and Medicine

Gregoriadis, G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609302951406 · Cited by 321 · see citing works

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Feldman, E. J., Lancet, J. E., Kolitz, J. E., Ritchie, E. K., Roboz, G. J., List, A. F., Allen, S. L., Asatiani, E., Mayer, L. D., Swenson, C. E., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5961 · Cited by 310 · see citing works

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures

Hansen, C. B., Kao, G. Y., Moase, E. H., Zalipsky, S., & Allen, T. M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00138-s · Cited by 309 · see citing works

The Design of Cationic Lipids for Gene Delivery

Martin, B., Sainlos, M., Aissaoui, A., Oudrhiri, N., Hauchecorne, M., VIGNERON, J. ‐., Lehn, J., & Lehn, P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382133 · Cited by 304 · see citing works

Stabilized plasmid-lipid particles: construction and characterization

Wheeler, J. J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R. W., Zhang, Y. P., Hope, M. J., Scherrer, P., & Cullis, P. R. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300821 · Cited by 300 · see citing works

Skin structure and mode of action of vesicles

Bouwstra, J. A., & Honeywell‐Nguyen, P. L. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00114-x · Cited by 296 · see citing works

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.

Pastorino, F., Brignole, C., Marimpietri, D., Cilli, M., Gambini, C., Ribatti, D., Longhi, R., Allen, T. M., Corti, A., & Ponzoni, M. (2003) · PubMed · Cited by 296 · see citing works

Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer

Charrois, G. J. R., & Allen, T. M. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.006 · Cited by 292 · see citing works

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

Allen, T. M., Brandeis, E., Hansen, C. B., Kao, G. Y., & Zalipsky, S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00085-h · Cited by 288 · see citing works

Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases

Gregoriadis, G. C., & Ryman, B. E. (1971) · Biochemical Journal · doi:10.1042/bj1240058p · Cited by 286 · see citing works

Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs

Alving, C. R., Steck, E. A., Chapman, W. L., Waits, V. B., Hendricks, L. D., Swartz, G. M., & Hanson, W. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2959 · Cited by 284 · see citing works

Targeted Delivery of Antisense Oligodeoxynucleotide and Small Interference RNA into Lung Cancer Cells

Li, S., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282 · see citing works

Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times

Blume, G., Cevc, G., Crommelin, M. D. J. A., Bakker‐Woudenberg, I. A. J. M., Kluft, C., & Storm, G. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90039-3 · Cited by 282 · see citing works

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3

McDonagh, C. F., Huhalov, A., Harms, B. D., Adams, S., Paragas, V. B., Oyama, S., Zhang, B., Luus, L., Overland, R. P., Nguyen, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0820 · Cited by 278 · see citing works

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice

Newman, M. S., Colbern, G. T., Working, P. K., Engbers, C. M., & Amantea, M. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050855 · Cited by 275 · see citing works

Acoustically active liposomes for drug encapsulation and ultrasound-triggered release

Huang, S.-L., & MacDonald, R. C. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.07.003 · Cited by 268 · see citing works

The response of fluorescent amines to pH gradients across liposome membranes

Deamer, D. W., Prince, R. C., & Crofts, A. R. (1972) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(72)90180-0 · Cited by 266 · see citing works

Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodies

Maruyama, K., 知子, 滝., Yuda, T., Kennel, S. J., Huang, L., & Iwatsuru, M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00263-o · Cited by 265 · see citing works

Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.

Gabizón, A., Dagan, A., Goren, D., Barenholz, Y., & FUKS, Z. Y. (1982) · PubMed · Cited by 263 · see citing works

In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.

de Menezes, D. E. L., Pilarski, L. M., & Allen, T. M. (1998) · PubMed · Cited by 260 · see citing works

Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.

Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., & Low, P. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3318 · Cited by 257 · see citing works

The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey

Madden, T. D., Harrigan, P. R., Tai, L. C. L., Bally, M. B., Mayer, L. D., Redelmeier, T. E., Loughrey, H. C., Tilcock, C., Reinish, L. W., & Cullis, P. R. (1990) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(90)90131-a · Cited by 255 · see citing works

Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome

Suzuki, R., 知子, 滝., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Shinohara, A., Eriguchi, M., Yanagië, H., & Maruyama, K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.010 · Cited by 250 · see citing works

A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs

Ishida, T., Iden, D. L., & Allen, T. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01320-4 · Cited by 247 · see citing works

Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins

Scherphof, G. L., Roerdink, F. H., Waite, M. B., & Parks, J. S. (1978) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(78)90025-9 · Cited by 246 · see citing works

Ligand-Targeted Liposomes for Cancer Treatment

Sapra, P., Tyagi, P., & Allen, T. M. (2005) · Current Drug Delivery · doi:10.2174/156720105774370159 · Cited by 246 · see citing works

Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients

Mayer, L. D., Tai, L. C. L., Bally, M. B., Mitilenes, G. N., Ginsberg, R. S., & Cullis, P. R. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90091-2 · Cited by 245 · see citing works

Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.

Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242 · see citing works

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi’s sarcoma patients treated with pegylated liposomal doxorubicin

Berry, G. J., Billingham, M. E., Alderman, E. L., Richardson, P., Torti, F. M., Lum, B. L., Patek, A., & Martin, F. J. (1998) · Annals of Oncology · doi:10.1023/a:1008216430806 · Cited by 240 · see citing works

Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic Liposomes

Lappalainen, K., Jääskeläinen, I., Syrjänen, K. J., Urtti, A. O., & Syrjänen, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018932714745 · Cited by 238 · see citing works

Antibody Targeting of Liposomes: Cell Specificity Obtained by Conjugation of F(ab′) 2 to Vesicle Surface

Heath, T. D., Fraley, R. T., & Papahdjopoulos, D. (1980) · Science · doi:10.1126/science.7423203 · Cited by 237 · see citing works

Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy

Ryu, J. H., Koo, H., Sun, I., Yuk, S. H., Choi, K., Kim, K., & Kwon, I. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.012 · Cited by 235 · see citing works

Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy

Pastorino, F., Brignole, C., Paolo, D. D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 233 · see citing works

Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate

Guo, X. D., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 233 · see citing works

Spontaneous Entrapment of Polynucleotides upon Electrostatic Interaction with Ethanol-Destabilized Cationic Liposomes

Maurer, N., Wong, K. F., Stark, H., Louie, L. J., McIntosh, D. P., Wong, T., Scherrer, P., Semple, S. C., & Cullis, P. R. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76202-9 · Cited by 232 · see citing works

Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice.

Ahmad, I. N., Longenecker, M., Samuel, J., & Allen, T. M. (1993) · PubMed · Cited by 230 · see citing works

Liposomes for intravitreal drug delivery: A state of the art

Bochot, A., & Fattal, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.019 · Cited by 229 · see citing works

Chemotherapy-Associated Palmar-Plantar Erythrodysesthesia Syndrome

Lokich, J. J., & MOORE, C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-798 · Cited by 225 · see citing works

In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach

Iden, D. L., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00357-1 · Cited by 220 · see citing works

Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds

Martin, F. J., Hubbell, W. L., & Papahadjopoulos, D. (1981) · Biochemistry · doi:10.1021/bi00517a043 · Cited by 217 · see citing works

Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium

Torchilin, V. P., Klibanov, A. L., Huang, L., O'Donnell, S. M., Nossiff, N. D., & Khaw, B. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.9.1612296 · Cited by 216 · see citing works

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells

Ishida, T., Kirchmeier, M. J., Moase, E. H., Zalipsky, S., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00409-6 · Cited by 216 · see citing works

Interactions of liposomes with the reticuloendothelial system

Hsu, M. J., & Juliano, R. L. (1982) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(82)90120-3 · Cited by 215 · see citing works

Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes.

Bolotin, E. M., Cohen, R., Bar, L. K., Emanuel, N., Ninio, S., Barenholz, Y., & Lasiç, D. D. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037057 · Cited by 207 · see citing works

Control of the Rate of Hepatic Uptake and Catabolism of Liposome‐Entrapped Proteins Injected into Rats. Possible Therapeutic Applications

Gregoriadis, G. C., & Neerunjun, D. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03681.x · Cited by 207 · see citing works

Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS

James, N. D., Coker, R. J., Tomlinson, D., Harris, J. R. W., Gompels, M. M., Pinching, A. J., & Stewart, J. S. W. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80269-9 · Cited by 205 · see citing works

Fate of cationic liposomes and their complex with oligonucleotive in vivo

Litzinger, D. C., Brown, J. M., Wala, I., Kaufman, S. A., han, G. Y., Farrell, C. L., & Collins, D. W. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00268-5 · Cited by 201 · see citing works

Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial

Davidson, R. N., di Martino, L., Gradoni, L., Giacchino, R., RUSSO, R., Gaeta, G. B., Pempinello, R., Scott, S., Raimondi, F., Cascio, A., et al. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068903 · Cited by 196 · see citing works

Magnetically Responsive Microspheres and Other Carriers for the Biophysical Targeting of Antitumor Agents

Widder, K. J., Senyei, A. E., & Ranney, D. F. (1979) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60246-x · Cited by 195 · see citing works

Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells.

Poste, G. H., & Papahadjopoulos, D. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.5.1603 · Cited by 195 · see citing works

Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells

Mehta, R. T., Lopez‐Berestein, G., Hopfer, R. L., Mills, K., & Juliano, R. L. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90135-4 · Cited by 192 · see citing works

Liposomal Blockade of the Reticuloendothelial System: Improved Tumor Imaging with Small Unilamellar Vesicles

Proffitt, R. T., Williams, L. E., Presant, C. A., Tin, G. W., Uliana, J. A., Gamble, R. C., & Baldeschwieler, J. D. (1983) · Science · doi:10.1126/science.6836294 · Cited by 190 · see citing works

Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy

Chen, Y., Wu, J. J., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2009.291 · Cited by 185 · see citing works

Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.

Huang, S. K., Stauffer, P. R., Hong, K., Guo, J., Phillips, T. L., Huang, A., & Papahadjopoulos, D. (1994) · PubMed · Cited by 183 · see citing works

Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells

Basha, G., Novobrantseva, T. I., Rosin, N. L., Tam, Y. Y. C., Hafez, I. M., Wong, M., Sugo, T., Ruda, V. M., Qin, J., Klebanov, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.190 · Cited by 182 · see citing works

Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery by changes in lipid composition and incubation conditions

Fraley, R. T., Straubinger, R. M., Rule, G. S., Springer, E. L., & Papahadjopoulos, D. (1981) · Biochemistry · doi:10.1021/bi00527a031 · Cited by 180 · see citing works

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

Goren, D., Horowitz, A. T., Zalipsky, S., Woodle, M. C., Yarden, Y., & Gabizón, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.625 · Cited by 179 · see citing works

Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates

Senter, P. D., & Springer, C. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00206-x · Cited by 178 · see citing works

pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide.

Parente, R. A., Nir, S., & Szoka, F. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68843-x · Cited by 175 · see citing works

Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes

Patel, N. R., Rathi, A., Mongayt, D., & Torchilin, V. P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.082 · Cited by 174 · see citing works

Relationship between labeling indices of KI-67 and brdurd in human malignant tumors

Sasaki, K., Matsumura, K., Tsuji, T., Shinozaki, F., & Takahashi, M. (1988) · Cancer · doi:10.1002/1097-0142(19880901)62:5 · Cited by 172 · see citing works

Rate of biodistribution of STEALTH® liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity

Charrois, G. J. R., & Allen, T. M. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00661-2 · Cited by 170 · see citing works

Liposomes in cosmeceutics

Rahimpour, Y., & Hamishehkar, H. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.666968 · Cited by 167 · see citing works

Pharmacokinetics of liposome-encapsulated anti-tumor drugs

Juliano, R. L., & Stamp, D. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90252-6 · Cited by 166 · see citing works

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours

Francis, R. J., Sharma, S. K., Springer, C. J., Green, A. J., Hope‐Stone, L., Sena, L. A., Martin, J. E., Adamson, K., Robbins, A., Gumbrell, L. A., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600517 · Cited by 163 · see citing works

Localised drug release using MRI-controlled focused ultrasound hyperthermia

Staruch, R. M. T., Chopra, R., & Hynynen, K. (2010) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.518198 · Cited by 160 · see citing works

Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.

Allen, T. M., Mehra, T., Hansen, C., & Chin, Y. C. (1992) · PubMed · Cited by 159 · see citing works

Pegylated Liposomal Doxorubicin: Optimizing the Dosing Schedule in Ovarian Cancer

Rose, P. G. (2005) · The Oncologist · doi:10.1634/theoncologist.10-3-205 · Cited by 155 · see citing works

Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations

Johnston, M., Semple, S. C., Klimuk, S. K., Edwards, K., Eisenhardt, M. L., Leng, E. C., Karlsson, G., Yanko, D., & Cullis, P. R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.01.009 · Cited by 152 · see citing works

Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes

Vaage, J., Mayhew, E. G., Lasic, D. D., & Martin, F. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510618 · Cited by 150 · see citing works

Cationic Lipid Vectors for Plasmid DNA Delivery

Hirko, A. C., Tang, F., & Hughes, J. A. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457412 · Cited by 150 · see citing works

Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv

Xu, L., Tang, W., Huang, C., Alexander, W., Xiang, L., Pirollo, K. F., Rait, A. S., & Chang, E. H. (2001) · Molecular Medicine · doi:10.1007/bf03401962 · Cited by 148 · see citing works

Is half‐life of circulating liposomes determined by changes in their permeability?

Senior, J., & Gregoriadis, G. C. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81216-7 · Cited by 148 · see citing works

A Comparison of Depodur???, a Novel, Single-Dose Extended-Release Epidural Morphine, with Standard Epidural Morphine for Pain Relief After Lower Abdominal Surgery

Gambling, D. R., Hughes, T., Martin, G., Horton, W., & Manvelian, G. Z. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000145009.03574.78 · Cited by 148 · see citing works

Trigger release liposome systems: local and remote controlled delivery?

Bibi, S., Lattmann, E., Mohammed, A. R., & Perrie, Y. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.646330 · Cited by 147 · see citing works

Interactions of liposomes with the reticuloendothelial system effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles

Kao, Y. J., & Juliano, R. L. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90259-2 · Cited by 146 · see citing works

Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA

Mok, K. W. C., & Cullis, P. R. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78282-1 · Cited by 146 · see citing works

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma

Rodriguez, M. A., Pytlík, R., Kozák, T., Chhanabhai, M., Gascoyne, R. D., Lu, B., Deitcher, S. R., & Winter, J. N. (2009) · Cancer · doi:10.1002/cncr.24359 · Cited by 145 · see citing works

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial

Sarris, A. H., Hagemeister, F. B., Romaguera, J. E., Rodríguez, M., McLaughlin, P. J., Tsimberidou, A. M., Medeiros, L. J., Samuels, B. I., Pate, O., Oholendt, M. S., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008348010437 · Cited by 143 · see citing works

Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid

Mayhew, E. G., Lasiç, D. D., Babbar, S., & Martin, F. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510221 · Cited by 142 · see citing works

Lateral diffusion rates of phosphatidylcholine in vesicle membranes: Eeffects of cholesterol and hydrocarbon phase transitions

Cullis, P. R. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80762-4 · Cited by 139 · see citing works

Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue

Davidsen, J. R., Jørgensen, K., Andresen, T. L., & Mouritsen, O. G. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00659-4 · Cited by 138 · see citing works

Lipid-based amphotericin B: a review of the last 10 years of use

Hann, I. M., & Prentice, H. G. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00341-1 · Cited by 135 · see citing works

A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles

Allen, T. M. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90464-8 · Cited by 134 · see citing works

Liposomal daunorubicin as treatment for Kaposi’s sarcoma

Dittmer, D. P., & Petre, C. E. (2020) · PubMed · doi:10.17615/wyf0-9n94 · Cited by 132 · see citing works

Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study

Gabizón, A., Peretz, T., Sulkes, A., Amselem, S., Ben‐Yosef, R., Ben-Baruch, N. E., Catane, R., Biran, S., & Barenholz, Y. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90350-7 · Cited by 130 · see citing works

A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cells

Yavlovich, A., Singh, A., Blumenthal, R. P., & Puri, A. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.07.030 · Cited by 127 · see citing works

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN

de Jong, S. D., Chikh, G., Sekirov, L., Raney, S. G., Semple, S. C., Klimuk, S. K., Yuan, N., Hope, M., Cullis, P. R., & Tam, Y. K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0276-x · Cited by 127 · see citing works

Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.

Boman, N. L., Masin, D., Mayer, L. D., Cullis, P. R., & Bally, M. B. (1994) · PubMed · Cited by 126 · see citing works

From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010

Deamer, D. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-0503 · Cited by 125 · see citing works

Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts

Krauze, M. T., Noble, C. O., Kawaguchi, T., Drummond, D. C., Kirpotin, D. B., Yamashita, Y., Kullberg, E. B., Forsayeth, J., Park, J. W., & Bankiewicz, K. S. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-019 · Cited by 124 · see citing works

Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery

Muro, S., Koval, M. H., & Muzykantov, V. R. (2004) · Current Vascular Pharmacology · doi:10.2174/1570161043385736 · Cited by 122 · see citing works

Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity

Laginha, K. M., Mumbengegwi, D. R., & Allen, T. M. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.007 · Cited by 120 · see citing works

The swollen leg: ultrasonographic demonstration of non-thrombotic causes

Bell, J. M., Ross, F. G. M., Mackenzie, S., & Goddard, P. R. (1985) · Postgraduate Medical Journal · doi:10.1136/pgmj.61.711.23 · Cited by 119 · see citing works

Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study

Maurer, N., Wong, K. F., Hope, M. J., & Cullis, P. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00125-4 · Cited by 118 · see citing works

A comparison of the haemodynamic effects of propofol ('Diprivan') and thiopentone in patients with coronary artery disease.

Patrick, M. R., Blair, I., Feneck, R. O., & Sebel, P. S. (1985) · PubMed · Cited by 116 · see citing works

Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes.

Maruyama, K., Tsutomu, Y. U. D. A., Okamoto, A., Ishikura, C., Kojima, S., & Iwatsuru, M. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.1620 · Cited by 114 · see citing works

Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.

Storm, G., Roerdink, F. H., Steerenberg, P. A., de Jong, W. H., & Crommelin, D. J. A. (1987) · PubMed · Cited by 112 · see citing works

The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs

Richard, B. M., Newton, P. E., Ott, L. R., Haan, D., Brubaker, A. N., Cole, P. I., ROSS, P. E., Rebelatto, M. C., & Nelson, K. (2012) · Journal of Drug Delivery · doi:10.1155/2012/962101 · Cited by 111 · see citing works

Characterization of In Vivo Immunoliposome Targeting to Pulmonary Endothelium

Maruyama, K., Holmberg, E. G., Kennel, S. J., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600791107 · Cited by 110 · see citing works

Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.

Heath, T. D., Montgomery, J. A., Piper, J. R., & Papahadjopoulos, D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1377 · Cited by 108 · see citing works

Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.

Seetharamu, N., Kim, E., Höchster, H. S., Martin, F., & Muggia, F. M. (2010) · PubMed · Cited by 107 · see citing works

Delivery of c-myb Antisense Oligodeoxynucleotides to Human Neuroblastoma Cells Via Disialoganglioside GD2-Targeted Immunoliposomes: Antitumor Effects

Pagnan, G., Stuart, D. D., Pastorino, F., Raffaghello, L., Montaldo, P. G., Allen, T. M., Calabretta, B., & Ponzoni, M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.253 · Cited by 106 · see citing works

Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier".

Weinstein, J. N., & van Osdol, W. (1992) · PubMed · Cited by 104 · see citing works

Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel.

Cabanes, A., Briggs, K., Gokhale, P. C., Treat, J., & Rahman, A. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.5.1035 · Cited by 103 · see citing works

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer

Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Stathopoulos, J., Marosis, K., & Michalopoulou, P. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1572-5 · Cited by 102 · see citing works

Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis

Fasol, U., Frost, A., Büchert, M., Arends, J., Fiedler, U., Scharr, D., Scheuenpflug, J., & Mross, K. B. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr300 · Cited by 101 · see citing works

The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.

Kimelberg, H. K., Tracy, T. F., Biddlecome, S. M., & BOURKE, R. S. (1976) · PubMed · Cited by 99 · see citing works

Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles

Zhigaltsev, I. V., Winters, G. C., Srinivasulu, M., Crawford, J. B., Wong, M., Amankwa, L. N., Waterhouse, D., Masin, D., Webb, M. S., & Harasym, N. L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.029 · Cited by 99 · see citing works

A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability

Stuart, D. D., & Allen, T. M. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00209-6 · Cited by 99 · see citing works

Lyso-Thermosensitive Liposomal Doxorubicin: An Adjuvant to Increase The Cure Rate of Radiofrequency Ablation in Liver Cancer

Poon, R. T. P., & Borys, N. (2011) · Future Oncology · doi:10.2217/fon.11.73 · Cited by 99 · see citing works

Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution.

Allen, T. M., Murray, L., MacKeigan, S., & Shah, M. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21855-9 · Cited by 97 · see citing works

The bilayer stabilizing role of sphingomyelin in the presence of cholesterol. A 31P NMR study

Cullis, P. R., & Hope, M. J. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90225-4 · Cited by 97 · see citing works

Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers

Zhang, J. X. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 95 · see citing works

Influence of Drug-to-Lipid Ratio on Drug Release Properties and Liposome Integrity in Liposomal Doxorubicin Formulations

Johnston, M., Edwards, K., Karlsson, G., & Cullis, P. R. (2008) · Journal of Liposome Research · doi:10.1080/08982100802129372 · Cited by 94 · see citing works

A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1

Stuart, D. D., Kao, G. Y., & Allen, T. M. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700145 · Cited by 94 · see citing works

Delivery of a Liposomal c-raf-1 Antisense Oligonucleotide by Weekly Bolus Dosing in Patients with Advanced Solid Tumors

Rudin, C. M., Marshall, J. L., Huang, C. H., Kindler, H. L., Zhang, C., Kumar, D., Gokhale, P. C., Steinberg, J., Wanaski, S., Kasid, U. N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0642 · Cited by 92 · see citing works

Lipid-based systems for the intracellular delivery of genetic drugs

Maurer, N., Mori, A., Palmer, L., Monck, M. A., Mok, K. W. C., Mui, B. L., Akhong, Q.-F., & Cullis, P. R. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294869 · Cited by 92 · see citing works

Treatment of Acute Lymphoblastic Leukaemia

Apostolidou, E., Swords, R. T., Alvarado, Y., & Giles, F. J. (2007) · Drugs · doi:10.2165/00003495-200767150-00004 · Cited by 90 · see citing works

Antibody-mediated targeting of liposomes. Binding to lymphocytes does not ensure incorporation of vesicle contents into the cells

Weinstein, J. N., Blumenthal, R. P., Sharrow, S. O., & Henkart, P. A. (1978) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(78)90047-0 · Cited by 90 · see citing works

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · see citing works

Advances and Challenges of Liposome Assisted Drug Delivery

Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,672 · see citing works

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586 · see citing works

Lipid NanoparticlesFrom Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221 · see citing works

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164 · see citing works

Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

WICKI, A. N., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,912 · see citing works

The blood–brain barrier: Structure, regulation and drug delivery

Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906 · see citing works

Controlled Drug Delivery Systems: Current Status and Future Directions

Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,749 · see citing works

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636 · see citing works

Liposomes: Structure, composition, types, and clinical applications

Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561 · see citing works

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460 · see citing works

The evolution of commercial drug delivery technologies

Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361 · see citing works

Block copolymer micelles in nanomedicine applications

Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309 · see citing works

Smart cancer nanomedicine

van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F. M., Mulder, W. J. M., & Lammers, T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0567-y · Cited by 1,251 · see citing works

Design of liposomes as drug delivery system for therapeutic applications

Guimarães, D., Cavaco-Paulo, A. M., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,235 · see citing works

Lipid Nanoparticle Systems for Enabling Gene Therapies

Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208 · see citing works

Nanomaterials for cancer therapy: current progress and perspectives

Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,193 · see citing works

Liposomes and polymersomes: a comparative review towards cell mimicking

Rideau, E., Dimova, R., Schwille, P., Wurm, F. R., & Landfester, K. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00162f · Cited by 1,112 · see citing works

DNA Origami: Scaffolds for Creating Higher Order Structures

Fan, H. B., Zhang, F., Liu, Y., & Yan, H. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00825 · Cited by 1,090 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

The Smart Drug Delivery System and Its Clinical Potential

Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066 · see citing works

Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,063 · see citing works

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,089 · see citing works

Nanoparticles for Cancer Therapy: Current Progress and Challenges

Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069 · see citing works

Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles

Ernsting, M. J., Murakami, M., Roy, A., & Li, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,016 · see citing works

A review on phospholipids and their main applications in drug delivery systems

Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., & Deng, Y. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.09.004 · Cited by 1,005 · see citing works

Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review

Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998 · see citing works

Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine

Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864 · see citing works

Advances in Biomaterials for Drug Delivery

Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 869 · see citing works

Drug delivery by supramolecular design

Webber, M. J., & Langer, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00391a · Cited by 817 · see citing works

Humic acids: Structural properties and multiple functionalities for novel technological developments

de Melo, B. A. G., Motta, F. L., & Santana, M. H. A. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.12.001 · Cited by 789 · see citing works

Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 785 · see citing works

Clinical Translation of Nanomedicine

Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 794 · see citing works

Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization

Dehaini, D., Wei, X., Fang, R. H., Masson, S., Angsantikul, P., Luk, B. T., Zhang, Y., Man, Y. M., Jiang, Y., Kroll, A. V., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606209 · Cited by 775 · see citing works

Liposomes: Advancements and innovation in the manufacturing process

Shah, S. M., Dhawan, V. V., Holm, R., Nagarsenker, M. S., & Perrie, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.002 · Cited by 756 · see citing works

Engineering hybrid exosomes by membrane fusion with liposomes

Sato, Y. T., Umezaki, K., Sawada, S., Mukai, S.-A., Sasaki, Y., Harada, N., Shiku, H., & Akiyoshi, K. (2016) · Scientific Reports · doi:10.1038/srep21933 · Cited by 744 · see citing works

Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application

Lombardo, D., & Kiselev, M. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030543 · Cited by 738 · see citing works

Nanomedicine therapeutic approaches to overcome cancer drug resistance

Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733 · see citing works

Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box

Martins, P. H. D. F., de Jesus, J. T. C. L., dos Santos, S. N., Raposo, L. R., Roma‐Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2015) · Molecules · doi:10.3390/molecules200916852 · Cited by 738 · see citing works

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy

Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719 · see citing works

Supramolecular self-assemblies as functional nanomaterials

Busseron, E., Ruff, Y., Moulin, É., & Giuseppone, N. (2013) · Nanoscale · doi:10.1039/c3nr02176a · Cited by 699 · see citing works

The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery

Corbo, C., Molinaro, R., Parodi, A., Furman, N. E. T., Salvatore, F., & Tasciotti, E. (2015) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 704 · see citing works

Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs

Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 707 · see citing works

Supramolecular chemotherapy based on host–guest molecular recognition: a novel strategy in the battle against cancer with a bright future

Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 678 · see citing works

Magnetic nanocarriers: Evolution of spinel ferrites for medical applications

Amiri, M., Salavati‐Niasari, M., & Akbari, A. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.01.003 · Cited by 654 · see citing works

Novel methods for liposome preparation

Patil, Y. P., & Jadhav, S. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.10.011 · Cited by 640 · see citing works

PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time

Kooijmans, S. A. A., Fliervoet, L. A. L., van der Meel, R., Fens, M. H. A. M., Heijnen, H. F. G., Henegouwen, P. M. P. V. B. E., Vader, P., & Schiffelers, R. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.009 · Cited by 629 · see citing works

Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape

Zylberberg, C., & Matosevic, S. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1177136 · Cited by 629 · see citing works

Lipids and Lipid Derivatives for RNA Delivery

Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 638 · see citing works

mRNA vaccine delivery using lipid nanoparticles

Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624 · see citing works

Nanostructured lipid carriers for site-specific drug delivery

Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 622 · see citing works

Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source

Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 618 · see citing works

Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems

Kraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 614 · see citing works

Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery

Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040218 · Cited by 605 · see citing works

Hyaluronic acid for anticancer drug and nucleic acid delivery

Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596 · see citing works

Lipid nanoparticles enabling gene therapies: from concepts to clinical utility

Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592 · see citing works

Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges

Wen, H., Jung, H., & Li, X. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9814-9 · Cited by 575 · see citing works

Strategies, design, and chemistry in siRNA delivery systems

Dong, Y., Siegwart, D. J., & Anderson, D. G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.004 · Cited by 581 · see citing works

CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery

Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560 · see citing works

Nanoparticle-based drug delivery systems for cancer therapy

Dang, Y., & Guan, J. (2020) · Smart Materials in Medicine · doi:10.1016/j.smaim.2020.04.001 · Cited by 557 · see citing works

Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery

Wang, X., Liu, S., Sun, Y., Yu, X., Lee, S. M., Cheng, Q., Wei, T., Gong, J., Robinson, J. J., Zhang, D., et al. (2022) · Nature Protocols · doi:10.1038/s41596-022-00755-x · Cited by 567 · see citing works

Ligand-targeted liposome design: challenges and fundamental considerations

Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgiçer, B. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 543 · see citing works

Sperm-Hybrid Micromotor for Targeted Drug Delivery

Xu, H. C., Medina‐Sánchez, M., Magdanz, V., Schwarz, L., Hebenstreit, F., & Schmidt, O. G. (2017) · ACS Nano · doi:10.1021/acsnano.7b06398 · Cited by 541 · see citing works

Niosomes from 80s to present: The state of the art

Marianecci, C., Marzio, L. D., Rinaldi, F., Celia, C., Paolino, D., Alhaique, F., Esposito, S. A., & Carafa, M. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.11.018 · Cited by 536 · see citing works

Metal-organic frameworks for advanced drug delivery

He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 534 · see citing works

Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery

Eloy, J. O., de Souza, M. C., Petrilli, R., Barcellos, J. P. A., Lee, R. J., & Marchetti, J. M. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.029 · Cited by 535 · see citing works

Cyclodextrin-Based Host–Guest Supramolecular Nanoparticles for Delivery: From Design to Applications

Hu, Q., Tang, G., & Chu, P. K.-H. (2014) · Accounts of Chemical Research · doi:10.1021/ar500055s · Cited by 527 · see citing works

PEGylated liposomes: immunological responses

Sayed, M. M. E., Lila, A. S. A., Shimizu, T., Alaaeldin, E., Hussein, A. K., Sarhan, H. A., Szebeni, J., & Ishida, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1627174 · Cited by 536 · see citing works

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works

The 60-year evolution of lipid nanoparticles for nucleic acid delivery

Cullis, P. R., & Felgner, P. L. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00977-6 · Cited by 517 · see citing works

Nanomedicine review: clinical developments in liposomal applications

Beltran-Gracia, E., López-Camacho, A., Higuera‐Ciapara, I., Velázquez-Fernández, J. B., & Vallejo‐Cardona, A. A. (2019) · Cancer Nanotechnology · doi:10.1186/s12645-019-0055-y · Cited by 515 · see citing works

Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles

Mui, B. L., Tam, Y. K., Jayaraman, M., Ansell, S. M., Du, X., Tam, Y. Y. C., Lin, P. J. C., Chen, S., Narayanannair, J. K., Rajeev, K. G., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.66 · Cited by 509 · see citing works

The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors

Hatakeyama, H., Akita, H., & Harashima, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00059 · Cited by 500 · see citing works

Applications of nanoparticles for diagnosis and therapy of cancer

Baetke, S. C., Lammers, T., & Kiessling, F. M. (2015) · British Journal of Radiology · doi:10.1259/bjr.20150207 · Cited by 497 · see citing works

State-of-the-art materials for ultrasound-triggered drug delivery

Sirsi, S. R., & Borden, M. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.010 · Cited by 492 · see citing works

Extracellular vesicles as drug delivery systems: Lessons from the liposome field

van der Meel, R., Fens, M. H. A. M., Vader, P., van Solinge, W. W., Eniola‐Adefeso, O., & Schiffelers, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.049 · Cited by 483 · see citing works

Size‐Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting

Kang, H., Rho, S., Stiles, W. R., Hu, S., Baek, Y., Hwang, D. W., Kashiwagi, S., Kim, M. S., & Choi, H. S. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901223 · Cited by 483 · see citing works

Zeta potential: a case study of cationic, anionic, and neutral liposomes

Smith, M. C., Crist, R. M., Clogston, J. D., & McNeil, S. E. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0527-z · Cited by 482 · see citing works

Superhydrophobic materials for biomedical applications

Falde, E. J., Yohe, S. T., Colson, Y. L., & Grinstaff, M. W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.050 · Cited by 468 · see citing works

Application of Various Types of Liposomes in Drug Delivery Systems

Alavi, M., Karimi, N., & Safaei, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.002 · Cited by 466 · see citing works

Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy

Zhang, M., Xiao, B., Wang, H., Han, M. K., Zhang, Z., Viennois, É., Xu, C., & Merlin, D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.159 · Cited by 458 · see citing works

Exosome engineering: Current progress in cargo loading and targeted delivery

Fu, S., Wang, Y., Xia, X., & Zheng, J. C. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100261 · Cited by 444 · see citing works

Liposome production by microfluidics: potential and limiting factors

Carugo, D., Bottaro, E., Owen, J., Stride, E., & Nastruzzi, C. (2016) · Scientific Reports · doi:10.1038/srep25876 · Cited by 443 · see citing works

Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies

Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 448 · see citing works

Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes

Wu, I. Y., Bala, S., Škalko-Basnet, N., & di Cagno, M. P. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105026 · Cited by 439 · see citing works

pH-responsive injectable hydrogels with mucosal adhesiveness based on chitosan-grafted-dihydrocaffeic acid and oxidized pullulan for localized drug delivery

Liang, Y., Zhao, X., Ma, P. X., Guo, B., Du, Y., & Han, X. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.056 · Cited by 435 · see citing works

Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment

Li, R., He, Y., Zhang, S., Qin, J., & Wang, J. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.009 · Cited by 431 · see citing works

Liposomes in tissue engineering and regenerative medicine

Monteiro, N., Martins, A. M., Reis, R. L., & Neves, N. M. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0459 · Cited by 429 · see citing works

Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy

Chaturvedi, V. K., Singh, A., Singh, V. K., & Singh, M. P. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180918111528 · Cited by 420 · see citing works

Carbon dots: Biomacromolecule interaction, bioimaging and nanomedicine

Peng, Z., Han, X., Li, S., Al-Youbi, A. O., Bashammakh, A. S., El-Shahawi, M. S., & Leblanc, R. M. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.06.001 · Cited by 410 · see citing works

Overcoming Endosomal Entrapment in Drug Delivery

Pei, D., & Buyanova, M. Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00778 · Cited by 405 · see citing works

Supramolecular cancer nanotheranostics

Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411 · see citing works

Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives

Navya, P. N., & Daima, H. K. (2016) · Nano Convergence · doi:10.1186/s40580-016-0064-z · Cited by 404 · see citing works

Application of Light Scattering Techniques to Nanoparticle Characterization and Development

Carvalho, P. M., Felício, M. R., Santos, N. C., Gonçalves, S., & Domingues, M. M. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00237 · Cited by 402 · see citing works

Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy

Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399 · see citing works

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status

van der Meel, R., Vehmeijer, L. J. C., Kok, R. J., Storm, G., & van Gaal, E. V. B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.012 · Cited by 398 · see citing works

Delivery strategies for sustained drug release in the lungs

Loira-Pastoriza, C., Todoroff, J., & Rita Vanbever, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.017 · Cited by 395 · see citing works

Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances

Gandhi, N. S., Tekade, R. K., & Chougule, M. B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.001 · Cited by 397 · see citing works

Lipid nano scale cargos for the protection and delivery of food bioactive ingredients and nutraceuticals

Akhavan‐Mahdavi, S., Assadpour, E., Katouzian, I., & Jafari, S. M. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.02.001 · Cited by 393 · see citing works

Liposomal Delivery Systems: Design Optimization and Current Applications

Lila, A. S. A., & Ishida, T. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00624 · Cited by 386 · see citing works

NANOPARTICLES DRUG DELIVERY SYSTEM USING LIPOSOMES FOR CANCER TREATMENT

Juthi, A. Z., Bithi, T. Z., Babu, M. S. I., Talukder, M. E., & Hossen, M. S. (2005) · World Journal of Pharmaceutical and life sciences

Liposomal Medicine Drug Delivery Systems from Concept to Clinical Operation

Dhotre, S., Baokar, S., & Patil, R. (2025) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2025.v85i7.009

Progress with liposomal drug delivery systems: Formulation to therapy

Mahapatra, A. K., Murthy, P. N., Sravanthi, C. H., Ana, A., Swain, R. P., & Polei, N. (2014) · Der pharmacia lettre · Cited by 2 · see citing works

Lipopharmaceuticals- A Critical Review Focused on Recent Advances in Liposomal Drug Delivery

Rastogi, H., Shree, M., Srivastava, S., & Kaur, D. (2020) · INTERNATIONAL JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH (IJPER) · doi:10.37021/ijper.v2i1.2 · Cited by 2 · see citing works

LIPOSOMES AS DRUG DELIVERY SYSTEMS: A COMPREHENSIVE REVIEW WITH RECENT ADVANCES

Pal, A., Maurya, V. K., & Kumar, K. (2026) · GLOBAL JOURNAL OF PHARMACEUTICAL AND SCIENTIFIC RESEARCH · doi:10.66204/gjpsr-1124-2026-2-7-6